Show/Hide Menu

Engineering the medicines
of tomorrow

You are here

The future of healthcare will be built on truly differentiated drugs, biopharmaceuticals that help to improve patients’ lives tomorrow and can really make a difference in areas of unmet medical need. At MorphoSys, all disciplines and teams work hand in hand to facilitate the advancement of such compounds, from their discovery through to clinical development.

We believe that successful drug development is not a matter of chance, but based on a profound understanding of disease biology, excellent technologies and extensive experience in the selection, characterization and development of therapeutic candidates. 

MorphoSys’s technologies and the expertise of its employees in the development of biologics support the search for drug candidates with unique properties.

DR. MARLIES SPROLL
Chief Scientific Officer

With our skills and knowledge we have built a comprehensive portfolio of promising drug candidates. Our successful research alliances and proprietary development activities have led to more than 20 therapeutic antibodies in clinical trials so far. Going forward, we will concentrate even more on proprietary product development.

Technologies are an essential part of the development process of a compound. Smarter tools provide faster, more flexible and, ultimately, better-quality access to drug candidates. MorphoSys’s technologies are setting the standard for how antibodies will be made in the future. They provide rapid and direct access to fully human antibodies for use as research tools, diagnostics and therapeutics. 

Meet us at the following conferences

Wed-Thu
20-21
'17
Sep
Sep

Immuno-Oncology Frontiers

Berlin, Germany
Mon-Fri
13-17
'17
Nov
Nov

PEGS Europe

Lisboa, Portugal
Mon-Thu
08-11
'18
Jan
Jan

JP Morgan Healthcare Conference 2018

San Francisco, CA, USA
Mon-Thu
04-07
'18
Jun
Jun

BIO International Convention

Boston, USA
Wed-Tue
28-04
'18
Nov
Dec

ASH 2018 - 60th Annual Meeting

San Diego, USA

Related Links